Can Stem Cell-Delivered Platelets Fight Drug-Resistant Bacteria?- RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Qirui Lin et al:
“Can Stem Cell-Delivered Platelets Fight Drug-Resistant Bacteria?
MRSA infections remain a serious clinical challenge in the era of multidrug resistance.
Platelets are known to have antibacterial properties — but the mechanisms are incompletely understood, and whether induced pluripotent stem cell-derived platelets (iPSC-PLTs) share this capacity had never been tested.
A new study in RPTH Journal investigated the MRSA-killing potential of iPSC-PLTs and the mechanisms involved.
Key findings:
- All 3 iPSC-PLT clones demonstrated MRSA-killing capacity in vitro
- MyD88-deficient iPSC-PLTs showed impaired killing
- MRSA α-toxin (Hla) suppressed iPSC-PLT bactericidal function
iPSC-PLTs offer a unique advantage:
They are gene-editable, making them a powerful platform for investigating platelet antimicrobial function, and potentially a novel therapeutic tool against resistant infections.”
Title: Induced pluripotent stem cell-derived platelets kill multidrug-resistant Staphylococcus aureus via Toll-like receptor 2-MyD88 signaling and immunoglobulin G/FcyRIIA engagement
Authors: Qirui Lin, Kimiko Nonomura, Ieva Stirblyte, Sou Nakamura, Satoshi Uchiyama, Masaya Yamaguchi, Shigetada Kawabata, Miki Nagao, Katsue Suzuki-Inoue, Victor Nizet, Koji Eto, Naoshi Sugimoto
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 6, 2026, 18:08Trilok Chand: Microplastics Found in Human Testes and Blood Clots
-
Sep 6, 2026, 18:07Sarah Moharem Elgamal: Cardiovascular Imaging Beyond Anatomy Toward Earlier Risk Prediction
-
Sep 6, 2026, 16:41Christina (Tina) P.: APS – How it Happens in Your Blood, the Warning Signs, and What to Do about It
-
Sep 6, 2026, 16:33Jose Angel Nicolas Avila: How Tissue Mitochondrial Activity Dictates Macrophage Pool Size
-
Sep 6, 2026, 16:23Kevin Buda: Many High-Risk PE Patients Have Contraindications to Thrombolysis
-
Sep 6, 2026, 16:16Venk Murthy: 2018 vs 2026 ACC/AHA Lipid Guidelines – A Shift From RCTs to Expert Opinion?
-
Sep 6, 2026, 16:11Silmara Montalvão: Improving Global Hemophilia Diagnostics Through Sustained External Quality Assessment
-
Sep 6, 2026, 14:50Mohamed F Doheim: Unraveling the Symphony of Stroke Management
-
Sep 6, 2026, 14:47Ahmed Bennis: E-Cigarette Use and Early Cardiovascular Risk in Young Adults